期刊文献+

生长激素释放激素拮抗剂对人异位子宫内膜抑制增殖作用与cAMP信号通路相关 被引量:1

Growth Hormone-releasing Hormone Inhibits Proliferation of Human Ectopic Endometriotic Stromal Cells Possibly Through cAMP-dependent Signal Pathway
下载PDF
导出
摘要 目的研究生长激素释放激素拮抗剂对异位子宫内膜细胞增殖的作用及与cAMP信号通路的关系。方法异位子宫内膜组织采自子宫内膜异位症的妇女,分离异位子宫内膜基质细胞(ESC)。并加入GHRH拮抗剂JV-1-36培养。GHRH,GHRH受体(GHRH-R)和GHRH-R剪接变异体(SV)1 mRNA由反转录聚合酶链反应(RT-PCR)检测,细胞增殖通过细胞对BrdU的摄入来检测,放免法检测细胞内cAMP水平。结果 GHRH-R mRNA表达于ESC,而不表达于正常子宫内膜组织;SV1mRNA表达于正常子宫内膜及ESC。GHRH拮抗剂JV-1-36能降低异位子宫内膜基质细胞cAMP,减少细胞BrdU摄入。结论GHRH拮抗剂JV-1-36能抑制异位子宫内膜基质细胞增殖,其机制可能与cAMP信号通路有关。 Objective To study the inhibitory effect of GHRH antagonists on ectopic endometrial cell proliferation may be act through cAMP signal pathway. Methods Ectopic endometrial tissues were collected from women with endometriosis. Human eetopic en- dometrial stromal cells(ESC) were isolated and cultured. ESC were treated with GHRH antagonist JV - 1 -36. Expression of GHRH, GHRH receptor (GHRH -R) and GHRH -R splice variant (SV)1 mRNA were determined by reverse -transcription polymerase chain reaction ( RT - PCR). The ESC proliferation was assessed by 5 - bromo - 2 - deoxyuridine incorporation. Cyclic adenosine monophosphate (cAMP) levels was studied by ELISA. Results The ESCs,but not normal endometrial tissues, expressed GHRH - R mRNA. SV1 mR- NA was determined in normal endometrial tissues. In ESCs,JV -1 -36 reduced cAMP production and incorporation of BrdU. Conclusion GHRH antagonist JV - 1 - 36 can inhibit the proliferation of ectopic endometrial stromal cells and its mechanism may be related to the cAMP signaling pathway.
作者 黄勇 汪期明
出处 《医学研究杂志》 2013年第5期103-106,共4页 Journal of Medical Research
基金 浙江省医药卫生科技研究计划项目(2009B145)
关键词 子宫内膜异位症 剪接变异体1 生长激素释放激素拮抗剂 信号通路 环磷腺苷 Endometriosis SV1 GHRH antagonists Signal transduction cAMP
  • 相关文献

参考文献10

  • 1Hatok J,Zubor P, Galo S, et al. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis [J] . Gynecol Endocrinol,2011 ,27 (5) :331 - 336.
  • 2Hoa DB,Takayuki 0,Afit - Azzouzene D,et al. Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen [J]. J Immunol,2010,184(8) :4143 -4158.
  • 3Neil S, Yue F, Lijuan H, et al. Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells [ J]. Mol Endocrinol,2010,24( 1 ) : 148 -160.
  • 4Tang X, Yano T, Osuga Y, et al. Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH - releasing hormone antagonist cetrorelix [J]. J Clin Endocrinol Metab ,2002 ,87(8) :3721 -3727.
  • 5Fu L, Osuga Y, Yano T, Takemura Y, et al. Expression and possible implication of growth hormone - releasing hormone receptor splice variant 1 in endometriosis [J]. Fertil Steril,2009 ,92( 1) :47 - 53.
  • 6Martari M, Salvatori R. Diseases associated with growth hormone - releasing hormone receptor ( GHRHR) mutations [J]. Prog Mol Biol Transl Sci ,2009 ,88 :57 -84.
  • 7Khan MA, Sengupta J, Mittal S, et al. Genome - wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis [ J]. Reprod Biol Endocrinol,2012,10(1) :84.
  • 8Papadia A, Schally AV, Halmos G, et al. Growth hormone - releasing hormone antagonists inhibit growth of human ovarian cancer [ J]. Horm Metab Res,2011,43(11) :816 -820.
  • 9汪期明,黄勇.生长激素释放激素受体剪接变异体1在子宫内膜异位症中的表达[J].中国妇幼保健,2012,27(28):4441-4444. 被引量:3
  • 10Granata R, Trovato L, Gallo MP, et al. Growth hormone - releasing hormone promotes survival of cardiac myocytes in vitro and protects a-gainst ischaemia - reperfusion injury in rat heart [ J ]. CardiovascRes,2009,83(2) :303 -312.

二级参考文献10

  • 1Wu Y, Kajdacsy- Balla A, Strawn E et al. Transcriptional characterizations of differences between eutopic and ectopic en- dometrium [J]. Endocrinology, 2006, 147:232.
  • 2Kiaris H, Sehally AV, Kalofoutis A. Extrapituitary effects of the growth hormone - releasing hormone [ J ] . Vitam Horm, 2005, 70:1.
  • 3Hoa Duong B, Takayuki O, Ai't- Azzouzene D et al. Periphe- ral B cell tolerance and function in transgenic mice expressing an IgD superantigen [ J]. J Immuno1,2010,184 (8):4143.
  • 4Neil S, Yue F, Lijuan H et al. Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells [J]. Mol Endocrinol, 2010, 24 (1): 148.
  • 5Tang X, Yano T, Osuga Yet al. Cellular mechanisms ofgrowth inhibition of human epithelial ovarian cancer cell line by LH - releasing hormone antagonist Cetrorelix [ J ]. J Clin Endocrinol Metab, 2002, 87:3721.
  • 6Schulz S, Rocken C, Schulz S. Immunocytochemical localisa- tion of plasma membrane GHRH receptors in human tumours u- sing a novel anti - peptide antibody [ J] . Eur J Cancer, 2006, 42:2390.
  • 7Gallego R, Pintos E, Garcia - Caballero T et al. Cellular dis- tribution of growth hormone - releasing hormone receptor in hu- man reproductive system and breast and prostate cancers [J]. Histol Histopathol, 2005, 20:697.
  • 8Rekasi Z, Czompoly T, Schally AV et al. Isolation and se- quencing of cDNAs for splice variants of growth hormone - re- leasing hormone receptors from human cancers [ J] . Proc Natl Acad Sci USA, 2000, 97:10561.
  • 9Morimoto C, Osuga Y, Yano T et al. GnRH II as a possible cytostatic regulator in the development of endometriosis [J]. Hum Reprod, 2005, 20:3212.
  • 10Barabutis N, Schally AV. Knocking down gene expression for growth hormone - releasing hormone inhibits proliferation of human cancer cell lines [ J] . Br J Cancer, 2008, 98 (11) : 1790.

共引文献2

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部